Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4H297 | — |
Expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired drug administered in a 80-year-old male patient who received HBV (Engerix B) (batch number 4H297, expiry date 06-APR-2025) for prophylaxis. Concurrent medical conditions included hemodialysis. On 23-APR-2025, the patient received Engerix B. On 23-APR-2025, an unknown time after receiving Engerix B, the patient experienced expired drug administered (Verbatim: Expired dose administered). The outcome of the expired drug administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-APR-2025 Patient Supervisor called to inform that earlier that day, a dose of Engerix-B was given 15 days after expiration date which led to Expired drug administered. According to the reporter, the patient was under the hemodialysis schedule, so they receive 2 syringes (40 mcg) of Engerix-B. Reporter did not specify if in that visit the two syringes were administered, and if so, if it was only one of the two syringes that was expired.
Hemodialysis